Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
665.00    -7.00 (-1.04%)
Bid:
664.00
Ask:
666.00
Spread: 2.00 (0.301%)
Market Cap: £541.28m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

8 Dec 2025 10:05

RNS Number : 6484K
Bloomsbury Publishing PLC
08 December 2025
 

08 December 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

The Company was made aware today that, as part of a dividend reinvestment plan, John Bason, the Company's Non-executive Chairman, purchased 90 ordinary shares of £0.0125 ("Ordinary Shares") on the market at a price of 496.84 pence per Ordinary Share on 28 November 2025. Following this transaction, he (including persons closely associated with him) holds a total of 23,109 shares in the Company, representing approximately 0.03% of the current Issued Share Capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation), which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Bason

2

Reason for the notification

a)

Position/status

Non-executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Share purchase

 

c)

Price(s) and volume(s)

Price

No. of shares

£4.9684

90

d)

Aggregated information

 

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

AQSE Trading (Equity)

 

 

 For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGBDDDGGDGUI
Date   Source Headline
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:41 pmRNSDirector/PDMR Shareholding
9th Jun 201612:39 pmRNSDirector/PDMR Shareholding
27th May 20162:21 pmRNSEmployee Benefit Trust purchase of shares
24th May 20164:35 pmRNSEmployee Benefit Trust purchase of shares
23rd May 201611:14 amRNSBlock Listing Six Monthly Return
19th May 20167:00 amRNSPreliminary Results
19th Apr 20163:19 pmRNSHolding(s) in Company
15th Apr 20164:22 pmRNSHolding(s) in Company
15th Apr 20164:09 pmRNSHolding(s) in Company
19th Feb 20162:12 pmRNSHolding(s) in Company
29th Jan 20166:28 pmRNSTotal Voting Rights
22nd Jan 20163:02 pmRNSCompletion of Acquisition
18th Jan 201612:20 pmRNSDirector/PDMR Shareholding
18th Jan 201612:19 pmRNSDirector/PDMR Shareholding
18th Jan 201612:17 pmRNSDirector/PDMR Shareholding
18th Jan 201612:16 pmRNSDirector/PDMR Shareholding
21st Dec 20155:35 pmRNSAcquisition
18th Nov 20155:23 pmRNSBlock Listing Six Monthly Return
27th Oct 20157:00 amRNSInterim Results
7th Oct 20153:07 pmRNSDirector/PDMR Shareholding
18th Sep 20151:04 pmRNSDirector/PDMR Shareholding
18th Sep 20151:04 pmRNSDirector/PDMR Shareholding
25th Aug 201512:08 pmRNSHolding(s) in Company
25th Aug 201512:03 pmRNSHolding(s) in Company
29th Jul 201512:53 pmRNSDirector/PDMR Shareholding
29th Jul 201512:53 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
29th Jul 201512:49 pmRNSDirector/PDMR Shareholding
23rd Jul 20154:42 pmRNSAGM Statement
23rd Jul 201512:00 pmRNSDirectorate Change
23rd Jul 20157:00 amRNSTrading Statement
6th Jul 20155:36 pmRNSDirector/PDMR Shareholding
6th Jul 20155:34 pmRNSDirector/PDMR Shareholding
25th Jun 20154:54 pmRNSAnnual Financial Report
18th Jun 201511:27 amRNSHolding(s) in Company
5th Jun 20154:07 pmRNSDirector/PDMR Shareholding
4th Jun 20151:15 pmRNSHolding(s) in Company
4th Jun 20151:13 pmRNSHolding(s) in Company
28th May 20158:28 amRNSHolding(s) in Company
21st May 201510:23 amRNSDirector/PDMR Shareholding
19th May 20155:00 pmRNSBlock Listing Six Monthly Return
19th May 20157:00 amRNSPreliminary Results
18th Mar 20157:00 amRNSTrading Statement
3rd Mar 20153:30 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSTotal Voting Rights
29th Jan 20155:51 pmRNSHolding(s) in Company
9th Jan 20158:37 amRNSDirector/PDMR Shareholding
9th Jan 20158:35 amRNSDirector/PDMR Shareholding
9th Jan 20158:34 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.